Chemours Company (CC) AI Stock Analysis

• Market Cap: $2.29B
• Dividend Yield: 4.37%
• Average Volume (3M): 2.32M
• Price to Earnings (P/E): ―
• Beta (1Y): 2.17
• Revenue Growth: 2.12%
• EPS Growth: -579.74%
• Country: US
• Employees: 6,000
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 0.20
• Shares Outstanding: 149,891,950
• 10 Day Avg. Volume: 3,172,140
• 30 Day Avg. Volume: 2,324,396
• PEG Ratio: -0.22
• Price to Book (P/B): 4.18
• Price to Sales (P/S): 0.44
• P/FCF Ratio: -2.54
• Enterprise Value/Market Cap: 2.71
• Enterprise Value/Revenue: 1.06
• Enterprise Value/Gross Profit: 6.07
• Enterprise Value/Ebitda: 9.43
• 1Y Price Target: $17.25
• Price Target Upside: 7.54% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 8
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 54 Neutral
• Price Target: $16.00 ▼(-0.25% Downside)

The score is held back primarily by deteriorating financial performance (declining revenue, negative profitability, weak cash flow and high leverage). Technical momentum is strong but appears overextended, while valuation is mixed due to losses despite a solid dividend yield. Earnings call commentary and the Taiwan land sale add some support via Opteon growth and debt-reduction actions, but near-term TiO2 weakness and guided sequential sales decline temper the outlook.

Positive Factors

Opteon Sales Growth

The strong growth in Opteon sales demonstrates Chemours' successful penetration in the refrigerants market, which is likely to sustain revenue growth and improve profitability in the long term.

Loan Maturity Extension

Extending the loan maturity provides Chemours with increased financial flexibility and stability, allowing more time for strategic investments and debt management, which supports long-term financial health.

Technical Qualification in TSS

This technical qualification enhances Chemours' position in the liquid cooling market, potentially driving future growth and innovation in the TSS segment.

Negative Factors

Declining Revenue

Declining revenue indicates challenges in market demand and competitiveness, which can hinder long-term growth and profitability if not addressed.

High Leverage

High leverage can strain financial resources and limit strategic flexibility, potentially impacting Chemours' ability to invest in growth opportunities.

Weak Cash Flow Generation

Weak cash flow generation limits Chemours' ability to fund operations and invest in growth, posing a risk to long-term financial stability.

Chemours Company Business Overview & Revenue Model

Company Description

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

How the Company Makes Money

Chemours generates revenue primarily through the sale of its core products across its three business segments. The Titanium Technologies segment is a significant source of income, producing titanium dioxide, which is widely used as a pigment in paints, coatings, and plastics. The Fluoroproducts segment includes a variety of fluorinated products that are essential in refrigeration, air conditioning, and other industrial applications. The Chemical Solutions segment provides custom and specialty chemicals for various applications. Additionally, Chemours has established key partnerships and collaborations within the industry that enhance its market reach and product offerings. The company also focuses on operational efficiency and cost management to bolster its profit margins, contributing to its overall financial performance.

Chemours Company Financial Statement Overview

Summary

Weak fundamentals: TTM revenue down (-10.2%), margins compressed (gross margin 17.37% vs 21.67% in 2023) and net margin negative (-5.67%). Leverage remains meaningful (D/E 0.86) with very low equity ratio (3.94%) and sharply negative ROE (-77.53%). Cash generation deteriorated with free cash flow growth at -120% and weak operating cash flow relative to earnings.

Income Statement

The income statement shows a declining trend in revenue with a negative revenue growth rate of -10.2% in TTM. Gross profit margin has decreased from 21.67% in 2023 to 17.37% in TTM, indicating reduced profitability. The net profit margin is negative at -5.67% in TTM, reflecting a net loss. EBIT and EBITDA margins have also declined, highlighting operational challenges.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio of 0.86 in TTM, which is an improvement from previous years but still indicates significant leverage. Return on equity is negative at -77.53% in TTM, due to net losses, which is concerning. The equity ratio stands at 3.94%, showing a low proportion of equity financing.

Cash Flow

Cash flow analysis indicates a substantial decline in free cash flow growth at -120% in TTM. The operating cash flow to net income ratio is 0.14, suggesting weak cash generation relative to net income. The free cash flow to net income ratio is low at 2.64%, reflecting limited free cash flow relative to net losses.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.87B	5.78B	6.08B	6.83B	6.34B	4.97B
Gross Profit	1.02B	1.15B	1.31B	1.62B	1.38B	1.07B
EBITDA	658.00M	692.00M	197.00M	1.20B	1.18B	767.00M
Net Income	-333.00M	86.00M	-238.00M	578.00M	608.00M	219.00M
Balance Sheet
Total Assets	7.57B	7.51B	8.25B	7.64B	7.55B	7.08B
Cash, Cash Equivalents and Short-Term Investments	613.00M	713.00M	1.20B	1.10B	1.45B	1.10B
Total Debt	4.42B	4.36B	4.30B	3.88B	3.99B	4.28B
Total Liabilities	7.27B	6.91B	7.51B	6.53B	6.47B	6.27B
Stockholders Equity	298.00M	604.00M	737.00M	1.11B	1.08B	813.00M
Cash Flow
Free Cash Flow	-12.00M	-993.00M	186.00M	448.00M	537.00M	540.00M
Operating Cash Flow	265.00M	-633.00M	556.00M	755.00M	814.00M	807.00M
Investing Cash Flow	-270.00M	-353.00M	-229.00M	-284.00M	220.00M	-234.00M
Financing Cash Flow	-4.00M	-36.00M	172.00M	-686.00M	-554.00M	-449.00M

Chemours Company Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 16.04
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CC, the sentiment is Positive. The current price of 16.04 is above the 20-day moving average (MA) of 13.70, above the 50-day MA of 12.75, and above the 200-day MA of 12.90, indicating a bullish trend. The MACD of 0.95 indicates Negative momentum. The RSI at 74.15 is Negative, neither overbought nor oversold. The STOCH value of 79.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CC.

Chemours Company Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ASH	60 Neutral	$2.80B	-3.45	-34.45%	2.79%	-13.67%	-608.89%
NGVT	59 Neutral	$2.34B	-37.52	-38.91%	―	-13.39%	88.25%
KWR	58 Neutral	$2.60B	-314.88	-0.64%	1.37%	0.08%	-107.33%
CC	54 Neutral	$2.29B	-7.23	-69.74%	4.37%	2.12%	-579.74%
IOSP	54 Neutral	$1.96B	-1,388.61	-0.09%	2.19%	-4.49%	-100.80%
OLN	52 Neutral	$2.57B	51.40	2.67%	3.91%	4.68%	-62.80%

Chemours Company Corporate Events

Chemours to Sell Taiwan Site Land, Reduce Debt

On January 15, 2026, Chemours signed definitive agreements through its Taiwanese subsidiary to sell the remaining land at its former titanium dioxide manufacturing site in Kuan Yin, Taiwan, comprising ten parcels, to a buyer group led by Century Wind Power, Century Iron & Steel Industrial, and Century Huaxin Wind Energy for approximately $360 million. The industrial real estate transaction, negotiated on an arm’s-length basis and subject to customary regulatory and environmental approvals, is expected to substantially close by mid-2026 and will see Chemours use the cash proceeds to reduce debt, advancing its balance-sheet deleveraging efforts following the dismantling and removal of the Kuan Yin site completed in the first quarter of 2025.

The most recent analyst rating on (CC) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Chemours Company stock, see the CC Stock Forecast page.

Chemours Approves New Executive Severance Policy

On October 28, 2025, The Chemours Company‘s Board of Directors approved a new Executive Severance Policy to provide payments and benefits to executive officers and certain employees upon specified terminations of employment. This policy aims to offer financial security to executives in cases of involuntary termination without cause or resignation for good reason, potentially impacting the company’s operational stability and employee retention strategies.

The most recent analyst rating on (CC) stock is a Hold with a $13.50 price target. To see the full list of analyst forecasts on Chemours Company stock, see the CC Stock Forecast page.